Inflammation Research

3.8k papers and 86.9k indexed citations i.

About

The 3.8k papers published in Inflammation Research in the last decades have received a total of 86.9k indexed citations. Papers published in Inflammation Research usually cover Immunology (1.6k papers), Molecular Biology (1.3k papers) and Physiology (576 papers) specifically the topics of Mast cells and histamine (523 papers), Immune Response and Inflammation (441 papers) and Asthma and respiratory diseases (300 papers). The most active scholars publishing in Inflammation Research are John R. Vane, R M Botting, Jan Hošek, Bengt‐Olof Nilsson, Giulia Chinetti, Bart Staels, Jean‐Charles Fruchart, Jan Korbecki, H. G. Schwelberger and András Falus.

In The Last Decade

Fields of papers published in Inflammation Research

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Inflammation Research. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Inflammation Research

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Inflammation Research. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Inflammation Research with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025